Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTNT.L Regulatory News (TNT)

  • There is currently no data for TNT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

9 Jun 2023 15:43

RNS Number : 2953C
Tintra PLC
09 June 2023
 

 

9 June 2023

TINTRA PLC

 ("TNT", the "Group" or the "Company")

 

Business Update

 

 

The board of directors (the "Board") of Tintra, the rapidly innovating Deep Tech & Banking business, is pleased to provide the following update on its business.

 

Further to the announcement of 8 May 2023, regarding the establishment of a new banking hub in African, Tintra has progressed various conversations in that country and last week with the Rwanda Development Board. As a result the Company is now in the final stages of preparing a Regulated Business Plan for submission to the National Bank of Rwanda which it currently expects to be submitting before the end of July 2023. To progress this ongoing work further a Tintra team will be in Rwanda on the week of the 19 June 2023 in order to meet with local stakeholders.

 

Further, the Company has formed a Rwandan entity to facilitate the application and is in the final stages of a reaching a commercial agreement with an established local partner to enter into a Joint Venture that will accelerate the roll out into that region.

 

The matter referenced on 5 May 2023 between Fintech Leaders Fund LLC and the Company is ongoing, with initial court proceedings expected during July and with a latest date set by the Court for Final Hearing of 15 December 2023. The Company is engaged in settlement negotiations and is hopeful of reaching agreement much sooner than that date, however this cannot be guaranteed.

 

Further to the Company's announcement on 25 January 2023 regarding the development of a Central Asia hub in Azerbaijan, the Company has been progressing this strategy and accordingly is sending a team to Baku, Azerbaijan, on 13 and 14 June 2023 where team members will be speaking to fintech and business leaders about Tintra's penetration into that market and beyond into Central Asia. The conversation with local regulators is ongoing and an update will be made prior to the submission of a licensing application.

 

Further to the Company's announcement of 10 March 2023 regarding an investment by a Middle Eastern investor, which was due to close within 45 days, the Company updates that the parties remain in close contact progressing the investment and have mutually agreed an extension until the 10 July 2023 and will make further announcements in due course.

 

Further to the Company's announcement of 13 March 2023 about the award of its patent number 11615399 by the United States Patent Office, the Company is pleased to announce that it yesterday applied to expand geographical coverage into areas and regions where it plans future business.

 

This establishment of IP protection globally is driven by the Company's mission of building Web3 technologies in highly regulated environments, especially in light of recent developments, as seen in the press, in this regard in the United States.

 

This two-pronged approach, firstly via the International Patent Systems Patent Co-operation System which covers more than 150 countries global, alongside additional direct applications in countries and regions of specific commercial interest, which includes Puerto Rico, Singapore, Japan, Korea and Mexico is supported by a regional Gulf Cooperation Council application covering the Tintra base in the Middle East.

 

For further information, contact:

 

Tintra PLC

(Communications Head)

Hannah Haffield

h.haffield@tintra.com

Website www.tintra.com

 

020 3795 0421

 

Allenby Capital Limited

(Nomad, Financial Adviser & Broker)

John Depasquale / Nick Harriss / Vivek Bhardwaj

 

020 3328 5656

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBSGDLBSGDGXC
Date   Source Headline
2nd Jun 20237:00 amRNSTotal Voting Rights & Licence Update
25th May 20232:17 pmRNSUpdate on UK Licence Application
23rd May 20239:38 amRNSReplacement - Director/PDMR Shareholding
16th May 20232:00 pmRNSNew Patent Applications
5th May 202312:32 pmRNSUpdate in relation to the Placement Facility
4th May 20237:00 amRNSConversion of Loan Stock and Total Voting Rights
6th Apr 20231:08 pmRNSRepayment Under Placement Facility
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 202311:55 amRNSParticipation in the Call to Advance Democracy
30th Mar 20233:00 pmRNSDirector/PDMR Shareholding
17th Mar 20232:15 pmRNSDirector/PDMR Shareholding
13th Mar 20233:07 pmRNSNotification of US Patent to Protect Web3 IP
10th Mar 202310:30 amRNSStrategic investment under current funding round
9th Mar 20237:00 amRNSKey Management Appointment & Directorate Change
8th Mar 20239:30 amRNSTintra to establish new hub in Rwanda
3rd Feb 20237:00 amRNSKey Management Appointment
2nd Feb 202311:00 amRNSUpdate on US Patent Applications
30th Jan 20237:45 amRNSIssue of Ordinary Shares Under Funding Round
25th Jan 20237:00 amRNSAppointment of Chief Operating Officer
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSTotal Voting Rights
21st Dec 20221:00 pmRNSHolding(s) in Company
16th Dec 20227:30 amRNSUS$10,000,000 Placement Facility
16th Dec 20227:00 amRNSStrategic Investment Under Current Funding Round
30th Nov 20223:31 pmRNSUpdate on Funding Round
8th Nov 20229:00 amRNSIssue of Convertible Loan Notes & PCA Holding
8th Nov 20227:30 amRNSBusiness Update
27th Oct 20227:00 amRNSHalf-year Report to 31 July 2022
18th Oct 202212:00 pmRNSUpdate on PPS Asset Realisation Co Limited
4th Oct 202212:00 pmRNSTotal Voting Rights
27th Sep 20227:00 amRNSUpdate on PPS Asset Realisation Co Limited
22nd Sep 20227:00 amRNSAppointment of Chief Innovation Officer
21st Sep 20226:00 pmRNSExercise of Options & Conversion Rights
21st Sep 202211:05 amRNSResult of Adjourned AGM
14th Sep 202210:30 amRNSGranting of Middle East Licence
14th Sep 20227:00 amRNSContract with Temenos for Core Banking Software
24th Aug 202210:30 amRNSNotice of Reconvening of AGM & Supplementary Note
1st Aug 20227:00 amRNSFinal Results & Annual Report for Yr to 31 Jan 22
29th Jul 202210:36 amRNSResult of AGM
29th Jul 20227:00 amRNSAGM Statement
11th Jul 20222:00 pmRNSUS Patent Application Filings to Protect Web3 IP
7th Jul 20227:00 amRNSFiling of UK Patent Application & Notice of AGM
28th Jun 20227:00 amRNSAI in banking needs to be 'explainable'
27th Jun 20227:00 amRNSAppointment of Chief Science Officer
16th Jun 20227:00 amRNSPatent Application
15th Jun 20227:00 amRNSWestern banks prefer metaverse to emerging markets
8th Jun 20227:00 amRNSThe importance of financial inclusion
20th May 20227:00 amRNSBusiness Update
29th Apr 20225:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.